Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

Clinical trial NCT01258374 · COMPLETED

Trial details

NCT number: NCT01258374
Sponsor: Hospital Clinic of Barcelona
Status: COMPLETED
Study type: OBSERVATIONAL

Integrase Inhibitors, HIV; HIV PROTEASE INHIB

Start date: 2010-05-01
Primary completion: 2011-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.